Latest Breaking News On - Delhi director randeep - Page 1 : comparemela.com

2577 Aditi Tandon New Delhi, May 11 Top Indian scientists and clinicians on Monday wrote an open letter to government Covid strategists demanding the removal of convalescent plasma therapy from national Covid clinical protocols and warned against possibilities of plasma use triggering virulent Covid variants while being of no clinical benefit among Covid patients. “Current research evidence unanimously indicates there is no benefit offered by convalescent plasma for treatment of COVID-19. However, it continues to be prescribed rampantly in hospitals across India. Families of patients run from pillar-to-post for getting plasma, which is in short supply and black marketing is common. Some very early evidence indicated a possible association between emergence of variants with lower susceptibility to neutralizing antibodies in immunosuppressed people given plasma therapy. This raises the possibility of more virulent strains developing due to irrational use of plasma therapy which

United statesNew delhiK vijay raghvanGautam menonAmar jesaniAditi tandonOomen johnShahid jameelGagandeep kangRandeep guleriaBalram bhargavaNational institutes of healthTribune news serviceDelhi director randeepIndian journalMedical ethics amar jesani